Search results

directly comparing the clinical and cost effectiveness of ranibizumab and bevacizumab in people with diabetic macular oedema should be...

Result type

Research recommendation

Published

9 June 2015

aflibercept 23 January 2014 TA118 Colorectal cancer (metastatic) - bevacizumab & cetuximab 27 November 2006 TA102 Conduct disorder in...

directly comparing the clinical and cost effectiveness of ranibizumab and bevacizumab in people with macular oedema secondary to retinal...

Result type

Research recommendation

Published

9 June 2015

Evidence-based recommendations on cabozantinib (Cabometyx) for advanced hepatocellular carcinoma in adults who have had sorafenib.

Result type

Technology appraisal guidance

Published

14 December 2022

Evidence-based recommendations on dexamethasone intravitreal implant (Ozurdex) for treating visual impairment caused by diabetic macular oedema in adults.

Result type

Technology appraisal guidance

Published

14 September 2022

Evidence-based recommendations on regorafenib (Stivarga) for previously treated metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Published

8 February 2023

Awaiting development [GID-TA11538] Expected publication date: TBC

Result type

Technology appraisal guidance

Status

Awaiting development

Discontinued [GID-TA10149]

Result type

Technology appraisal guidance

Status

Discontinued

Discontinued [GID-TAG413]

Result type

Technology appraisal guidance

Status

Discontinued

Discontinued [GID-TA10197]

Result type

Technology appraisal guidance

Status

Discontinued

Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the

Result type

Diagnostics guidance

Published

10 December 2014

Discontinued [GID-TAG432]

Result type

Technology appraisal guidance

Status

Discontinued

Evidence-based recommendations on nivolumab (Opdivo) with ipilimumab (Yervoy) and chemotherapy for untreated metastatic non-small-cell lung cancer.

Result type

Technology appraisal guidance

Published

8 September 2021

Evidence-based recommendations on tivozanib (Fotivda) for treating advanced renal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

21 March 2018

Evidence-based recommendations on dabrafenib (Tafinlar) with trametinib (Mekinist) for resected stage III, BRAF V600 mutation-positive melanoma in adults.

Result type

Technology appraisal guidance

Published

17 October 2018